+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

‘Global Bioactive Wound Care Market Worth $8,052m In 2021’ Says Visiongain Report

28 August 2018
Pharma

Visiongain’s new report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care indicates that the global bioactive wound care market will see $8,052m in spending in 2021.

The global bioactive wound care market is expected to grow at a CAGR of 8.7% in the first half of the forecast period and CAGR of 7.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 8.0% from 2017 to 2027. The market is estimated at $4,825 million in 2016, $8,052 million in 2021, and $12,420 million in 2027.

The lead analyst of the report said: “The bioactive wound care market is set to experience considerable growth over the next decade. The main drivers for the growth include an increasingly aging population, rising prevalence of diabetes and obesity, and growing patient awareness. In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk to one’s life. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year. The rising incidence provides an avenue for substantial growth in the bioactive wound care market over the coming years.”
The 213-page report contains 100 tables and 103 figures that add visual analysis in order to explain the developing trends within the Global Bioactive Wound Care Market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Biological Wound Care, Moist Wound Care, and Antimicrobial Wound Care.

The 213-page report offers market forecasts for the US, Canada, Germany, UK, Spain, Italy, France, Russia, Poland, Japan, China, India, South Korea, Australia, New Zealand, Brazil, Mexico, Turkey, Saudi Arabia, Israel and South Africa. In addition, the report contains a dedicated leading companies’ chapter covering companies leading the field in the bioactive wound care market.

The report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care report will be of value to anyone who wants to better understand the bioactive wound care market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the bioactive wound care industry.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read